Integrated Annual Report 2025

A woman smiles with her eyes closed while standing above a coastal town, with mountains and blue water in the background. (photo)

Elevating health at every life stage

Health, Nutrition & Care (HNC) helps people improve their health by supplementing their diet with critical nutrients. Working across segments such as Early Life Nutrition, Dietary Supplements, Pharma, Medical Nutrition, Biomedical materials, and Nutrition Improvement, we help to optimize immunity, accelerate recovery, and enhance quality of life.

At HNC, we recognize that creating a healthier world requires more than high-quality ingredients. That is why we aim to elevate global patient and consumer health at every stage of life. This commitment drives us to support our customers throughout the entire product development journey, serving as a true end-to-end partner. Our innovative product portfolio, coupled with customized solution offerings and expert service, provides unparalleled support from concept to consumer. These integrated capabilities ensure the right products, backed by the right expertise, giving our customers the strongest opportunity for success.

As we expand beyond ingredients, we are delivering evidence-based nutritional solutions enhanced by cutting-edge sensory science to help our customers develop products that resonate more deeply with consumers. Think of healthy longevity solutions that extend health span alongside lifespan. Or staying ahead of the competition and closer to consumers with science-backed, great-tasting solutions for gut health, maternal health, and pharmaceutical applications, all designed to perform while advancing sustainability for People and Planet with measurable impact. This is how we continue to evolve: by providing more effective solutions that meet the ever-changing needs of patients and consumers worldwide.

Highlights

In 2025, HNC delivered 3% organic sales growth and an 19.4% Adjusted EBITDA margin

We grew our HMO portfolio and drove synergistic symbiotic solutions for Early Life Nutrition with new regulatory approvals in key global markets

We accelerated the strategic transformation of our algal-based Omega-3 portfolio, helping customers shift to our highly sustainable algal life’s®OMEGA

We expanded our leadership in health from the gut with new launches in prebiotics, probiotics, and postbiotics

We strengthened our leadership in nutrition with several industry approvals and strategic launches, addressing key global consumer trends and needs with innovative solutions

We made significant progress in Biomedical strategy, innovation, and global expansion

i-Health drove growth in key accounts and brands, addressing frequently overlooked health issues, and took steps to strengthen its market position in 2026

2’-FL
2’-Fucosyllactose
AI
Artificial Intelligence
Bio-based
Bio-based refers to a material that is derived from a biological source, i.e. a living organism. This includes, but is not limited to, materials derived from plants, animals and fungi.
DHA
Docosahexaenoic Acid
EBITDA
Earnings Before Interest, Taxes, Depreciation and Amortization
EPA
Eicosapentaenoic Acid
GMO
Genetically Modified Organisms
HMO
Human Milk Oligosaccharides
HR
Human Resources
Organic sales growth
Organic sales growth is the sales growth excluding the impact of acquisitions, divestments, and currency impacts.
Scope 3
Scope 3 emissions are all indirect emissions (not included in scope 2) that occur in the value chain of the reporting company, including both upstream and downstream emissions.
UHMWPE
Ultra-High Molecular Weight Polyethylene
WBCSD
World Business Council for Sustainable Development

Topic filter

Results